Business Context and Reporting Period
Company: Microchip Technology Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended December 31, 1998
Industry Context: The semiconductor industry is characterized by flat to negative sales growth, low order visibility, and declining inventory levels. Microchip anticipates an industry-wide return to growth in the second half of the calendar year.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Dec 31, 1998 | Nine Months Ended Dec 31, 1998 | Nine Months Ended Dec 31, 1997 |
|---|---|---|---|
| Net Sales | $100,167 | $303,436 | $303,814 |
| Gross Profit | $50,642 | $151,373 | $151,338 |
| Gross Margin % | 50.6% | 49.9% | 49.8% |
| Operating Income | $25,120 | $67,272 | $67,101 |
| Net Income | $17,854 | $48,191 | $50,141 |
| Diluted EPS | $0.34 | $0.90 | $0.89 |
| Cash from Operations (9mo) | $70,184 | ||
| Cash and Equivalents (End Period) | $24,961 | ||
| Total Debt (Short + Long Term) | $43,581 |
Note: Total Debt includes $13.8M short-term lines of credit, $1.26M current maturities of long-term debt, $28.0M long-term lines of credit, and $0.52M long-term debt.
Material Changes vs. Prior Period
- Revenue: Net sales for the quarter decreased 3.3% year-over-year to $100.2 million. Nine-month sales were flat compared to the prior year ($303.4 million vs. $303.8 million).
- Profitability: Net income for the quarter increased 36% to $17.9 million, driven by improved gross margins (50.6% vs. 48.1% prior year) and lower operating expenses. Nine-month net income decreased slightly to $48.2 million.
- Cost Structure: Selling, general, and administrative expenses decreased 10.6% year-over-year in the quarter due to cost reduction programs. Research and development expenses increased slightly (1.3%) year-over-year.
- Special Charges: The prior year included a $5.0 million special charge in the quarter and $5.5 million in the nine-month period. The current period had no special charges, though a prior quarter charge of $5.5 million (legal settlement, obsolescence, restructuring) impacted the nine-month comparison.
- Liquidity: Cash and cash equivalents decreased by $7.2 million to $25.0 million, primarily due to significant stock repurchases ($70.3 million) and capital expenditures ($29.7 million).
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Restructuring: The Company plans to close its 5-inch wafer line (reducing capacity by ~20%) and restructure assembly/test operations. A special restructuring charge of $15 million to $17 million is expected in the March 1999 quarter.
- Acquisition Payment: A final payment for the Keeloq acquisition, estimated between $8 million and $15 million, is expected in the March 1999 quarter based on product performance.
- Capital Expenditures: The Company intends to spend approximately $70 million over the next 12 months to expand capacity and develop in-house assembly.
- Industry View: Management anticipates an industry-wide return to growth in the second half of the calendar year.
Risks and Contingencies
- Year 2000 (Y2K): The Company has spent approximately $14 million to date on Y2K remediation, with total costs expected not to exceed $18 million. No material Y2K issues were identified in products manufactured.
- Euro Conversion: Approximately 30% of sales are in Europe; however, 96% of European business is conducted in U.S. Dollars. No material impact is anticipated.
- Supply Chain: Reliance on third-party contractors for assembly and foreign facilities for testing introduces risks regarding yield, cost, and political stability.
- Pricing Pressure: Continued pricing pressure on memory products and certain microcontroller lines is expected due to competition.
Investor Verification Checklist
- Upcoming Charges: Verify the impact of the anticipated $15M-$17M restructuring charge and $8M-$15M Keeloq payment in the March 1999 quarter.
- Capacity Transition: Monitor the execution of the 5-inch wafer line closure and the transition to 6-inch/8-inch production to ensure no disruption in supply.
- Stock Repurchase Program: Review the remaining authorization and impact of the $70.3 million spent on buybacks during the nine-month period.
- Inventory Levels: Assess the reduction of inventory levels, which increased by $7.4 million in the nine-month period, against the backdrop of industry-wide inventory declines.
- Debt Covenants: Confirm continued compliance with financial ratios required by the $90 million domestic line of credit.